HAWTHORNE, NY, June 16, 2026 /24-7PressRelease/ -- Mike Celentano has been selected for inclusion in Marquis Who's Who. As in all Marquis Who's Who biographical volumes, individuals profiled are selected on the basis of current reference value. Factors such as position, noteworthy accomplishments, visibility, and prominence in a field are all taken into account during the selection process.

Mr. Celentano's distinguished career in systems engineering spans several decades and is marked by a series of progressive leadership roles and technical achievements within the healthcare and medical device industries. In 2024, he founded System Optimization Specialists, (SOS LLC), where he serves as owner, president and expert systems engineer. Through this consulting firm, Mr. Celentano assists organizations in advancing their systems engineering expertise, particularly within the healthcare sector. His work includes developing organizational standards for systems, designing training curricula and establishing competency frameworks for systems engineers. Notably, he recently partnered with a surgical robotics company specializing in hip and shoulder replacement systems to enhance its engineering processes. This project resulted in significant improvements for the client.

Prior to establishing his own firm, Mr. Celentano retired as senior director from Eli Lilly where he served from 2019 to 2024. In this capacity, he provided strategic direction for research and development initiatives, contributed to advancing medical technologies, developed new processes to incorporate systems engineering best practices and standards into the enterprise, and recruited some of the best MedTech systems engineers from around the world.

His tenure at Lilly was preceded by an extensive period at Roche Diagnostics where he held multiple positions over two decades. He started in 1999 as the first Systems Engineer hired by Roche Diagnostics R&D. By the time of his departure there were over 200 people performing systems engineering roles at Roche Diagnostics R&D globally.

Between 2011 and 2019, he served as program manager of adapted technologies, leading the efforts to mature potential technologies for the diabetes systems of the future. From 2003 to 2011, Mr. Celentano was research and development manager at Roche, leading multidisciplinary teams in the creation of advanced diagnostic instruments. His earlier role as principal systems engineer from 1999 to 2003 involved spearheading projects that bridged electrical engineering, software and mechanical design for medical devices.

In addition to his work at Roche, Mr. Celentano was engineering manager at United Medical Manufacturing from 1998 to 1999 and at Mitsubishi Chemical Corporation from 1995 to 1998. In these roles, he managed multi-disciplined teams responsible for developing new medical and lab systems.

His career began at Technicon (later Bayer AG) as an electro-optical, quality and system engineer from 1987 to 1995, where he contributed to the development of precision systems for clinical use.

Throughout his professional journey, Mr. Celentano has demonstrated expertise as a certified expert systems engineer in healthcare. He is recognized for consulting with companies seeking to optimize system processes, improve systems engineering practices and develop robust training programs for technical staff. He holds approximately thirteen global patents as an inventor—an achievement that underscores his commitment to innovation in medical technology.

Mr. Celentano's influence extends beyond his corporate roles through active participation in industry organizations. He served four years as technical director (director of technical operations) with the International Council on Systems Engineering (INCOSE) and remains engaged with its Healthcare Working Group—a group he founded around 2008 after recognizing a gap in the organization's focus on medical applications of systems engineering. Under his leadership, the Healthcare Working Group brought together professionals across the medical industry to advance global standards in healthcare systems engineering; it continues to thrive today with annual conferences and ongoing initiatives.

His academic foundation includes a Bachelor of Science in Electrical Engineering from New York Institute of Technology in Old Westbury, New York, earned in 1988. This degree provided him with a strong grounding in electronics and optics—skills that proved invaluable when he began his career at Technicon, where he developed large clinical analyzers for hospitals. The interdisciplinary nature of this early work inspired his passion for integrating multiple engineering disciplines into cohesive solutions for complex problems; a cornerstone of systems engineering.

Mr. Celentano further distinguished himself by earning the expert systems engineering professional certification from INCOSE in 2017—a credential that attests to his advanced knowledge, experience and leadership within the field.

He attributes much of his success to a genuine interest in understanding diverse perspectives—including business and cultural contexts—and emphasizes collaborative problem-solving over prescriptive solutions. This approach has enabled him to align teams effectively and deliver impactful results for stakeholders throughout his career. In recognition of his contributions, Mr. Celentano has received several awards from INCOSE as well as multiple service awards acknowledging his dedication to advancing the profession.

Beyond his technical pursuits, Mr. Celentano is a composer whose music is published on Spotify under the names Chell-n-Tano as well as Mike Celentano. His creative endeavors reflect a lifelong passion for the combination of art and technology—a trait influenced by family members such as his father Arnold Celentano, an accomplished electrical engineer at Bell Laboratories and his uncle Francis Celentano, an artist associated with the Op Art movement of the 1960s. Mike Celentano also enjoys inventing new technologies, such as energy-harvesting devices and innovative audio-generation methods. He is passionate about cooking—regularly entering competitions—and continues making music while supporting other artists in publishing their work.

Looking ahead, Mr. Celentano plans to increase his involvement in volunteer activities while continuing to consult within the medical field to promote best practices in systems engineering—a professional passion he hopes will have a lasting impact on industry standards. He also aims to release additional music albums, assist fellow artists with their creative projects and pursue new patents through ongoing invention efforts—all while embracing new opportunities following his relocation from Indiana to New York to be closer to family.

About Marquis Who's Who®:
Since 1899, when A. N. Marquis printed the First Edition of Who's Who in America®, Marquis Who's Who® has chronicled the lives of the most accomplished individuals and innovators from every significant field of endeavor, including politics, business, medicine, law, education, art, religion and entertainment. The suite of Marquis® publications, including Who's Who in America® and Who's Who in the World®, remains an essential biographical source for thousands of researchers, journalists, librarians and executive search firms around the globe. Marquis® publications can be viewed at the official Marquis Who's Who® website, www.marquiswhoswho.com.

# # #